Skip to main content

Breast Cancer

Breast Cancer, FDA Approvals, Oncology
Kisqali, a New CDK4/CDK6 Inhibitor, Approved as First-Line Therapy for HR-Positive, HER2-Negative Advanced Breast Cancer
Read More
Breast Cancer, Oncology
Extending Letrozole Therapy Beyond 5 Years in Early Breast Cancer Reduces Recurrence
Phoebe Starr
Read More
Breast Cancer, Oncology
ALTTO: Dual Anti-HER2 Adjuvant Therapy No Better than Trastuzumab Alone
Phoebe Starr
Read More
Breast Cancer, Oncology
Less May Be “More” with Zoledronic Acid
Caroline Helwick
Read More
Breast Cancer, Oncology
Adjuvant Exemestane More Effective than Tamoxifen in Early-Stage Breast Cancer
Wayne Kuznar
Read More
Breast Cancer, Oncology
New Data Confirm Benefits of 10 Years Tamoxifen versus 5 Years in Patients with ER-Positive Breast Cancer
Wayne Kuznar
Read More
Breast Cancer, Oncology
Chemotherapy-Related Toxicity Adds to Economic Burden in Metastatic Breast Cancer
Caroline Helwick
Read More
Breast Cancer, Oncology
Novel T-DM1 Prolongs Remission in Metastatic Breast Cancer: A New “Smart Bomb”
Audrey Andrews
Read More
Breast Cancer, Oncology
Regional Lymph Node Irradiation Indicated for Early Breast Cancer
Read More
Breast Cancer, Oncology
Exemestane: New Option for Breast Cancer Prevention
Read More
Page 3 of 3
Results 21 - 30 of 30